Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | 177Lu-DOTA-EB-TATE |
Synonyms | |
Therapy Description |
177Lu-DOTA-EB-TATE is a radioconjugate comprising of a somatostatin analog linked to Lu 177, which may inhibit tumor growth (PMID: 33355247). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
177Lu-DOTA-EB-TATE | Lutetium Lu 177-DOTA-EB-TATE|Lutetium Lu 177-DOTA-EB-Tyr3-Octreotate | 177Lu-DOTA-EB-TATE is a radioconjugate comprising of a somatostatin analog linked to Lu 177, which may inhibit tumor growth (PMID: 33355247). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05475210 | Phase I | 177Lu-DOTA-EB-TATE | 177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors | Recruiting | USA | 0 |